These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23185024)

  • 1. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
    Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
    Bale S; Julien JP; Bornholdt ZA; Kimberlin CR; Halfmann P; Zandonatti MA; Kunert J; Kroon GJ; Kawaoka Y; MacRae IJ; Wilson IA; Saphire EO
    PLoS Pathog; 2012 Sep; 8(9):e1002916. PubMed ID: 23028316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
    Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
    Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
    Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses.
    Albariño CG; Wiggleton Guerrero L; Spengler JR; Uebelhoer LS; Chakrabarti AK; Nichol ST; Towner JS
    Virology; 2015 Feb; 476():85-91. PubMed ID: 25531184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filoviral immune evasion mechanisms.
    Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
    Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
    Yen BC; Basler CF
    J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
    Feagins AR; Basler CF
    Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
    Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
    Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
    Yen B; Mulder LC; Martinez O; Basler CF
    J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.
    Leung DW; Prins KC; Borek DM; Farahbakhsh M; Tufariello JM; Ramanan P; Nix JC; Helgeson LA; Otwinowski Z; Honzatko RB; Basler CF; Amarasinghe GK
    Nat Struct Mol Biol; 2010 Feb; 17(2):165-72. PubMed ID: 20081868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of RNA aptamers targeting Ebola virus VP35.
    Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
    Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain.
    Leung DW; Shabman RS; Farahbakhsh M; Prins KC; Borek DM; Wang T; Mühlberger E; Basler CF; Amarasinghe GK
    J Mol Biol; 2010 Jun; 399(3):347-57. PubMed ID: 20399790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.
    Prins KC; Binning JM; Shabman RS; Leung DW; Amarasinghe GK; Basler CF
    J Virol; 2010 Oct; 84(20):10581-91. PubMed ID: 20686031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the Ebola VP35 interferon inhibitory domain.
    Leung DW; Ginder ND; Fulton DB; Nix J; Basler CF; Honzatko RB; Amarasinghe GK
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):411-6. PubMed ID: 19122151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marburg Virus Viral Protein 35 Inhibits Protein Kinase R Activation in a Cell Type-Specific Manner.
    Hume A; Mühlberger E
    J Infect Dis; 2018 Nov; 218(suppl_5):S403-S408. PubMed ID: 30165526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
    Guito JC; Albariño CG; Chakrabarti AK; Towner JS
    Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.